Clinical Trial: Supplemental Citicoline Administration to Reduce Lung Injury Efficacy Trial (SCARLET)
Study Status: Completed
Recruit Status: RECRUITING
Condition: COVID-19
Study Type: INTERVENTIONAL
Official Title: Supplemental Citicoline Administration to Reduce Lung Injury Efficacy Trial (SCARLET)
Brief Summary:
The goal of this single center, double-blinded, placebo-controlled, and randomized Phase 1 trial is to determine if i.v.citicoline is safe and efficacious compared to i.v.saline/control in adults presenting with SARS CoV-2 infection complicated by acute hypoxemic respiratory failure.The main questions it aims to answer:Is citicoline safe in this patient population?Does citicoline have a benefit in terms of improving oxygenation?Does citicoline reduce overall severity of illness as reflected by standardized…
Read more